Jubilant Pharmova Ltd Share Price
(JUBLPHARMA)
₹895.9▲0.81%
as on 04:01PM, 28 Mar 2025
Jubilant Pharmova Performance
Day's Low
Day's High
₹877.5Day's Price Range₹90452 Week's Low
52 Week's High
₹562.752-Week Price Range₹1,309.9
| Returns % | |
| 1 Month Return | -1.55 % |
| 3 Month Return | -19.03 % |
| 1 Year Return | + 55.94 % |
| Market Stats | |
| Previous Close | ₹888.70 |
| Open | ₹888.70 |
| Volume | 1.60L |
| Upper Circuit | ₹1,066.40 |
| Lower Circuit | ₹711.00 |
| Market Cap | ₹14,156.99Cr |
Jubilant Pharmova Fundamentals
P/E Ratio
22.45
PEG Ratio
0.6
Market Cap
₹14,156.99 Cr
P/B Ratio
3.81
EPS
4.6
Dividend Yield
0.88
Sector
Pharmaceuticals
ROE
1.32
Mutual Fund Holdings of Jubilant Pharmova
Jubilant Pharmova Analyst Rating
based on 2 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 2 analysts offering long term price targets for Jubilant Pharmova. An average target of ₹1310
Source: S&P Global Market Intelligence
Jubilant Pharmova Share analysis
Jubilant Pharmova price forecast by 2 analysts
Upside of47.41%
High
₹1385
Target
₹1310.00
Low
₹1235
Jubilant Pharmova target price ₹1310, a slight upside of 47.41% compared to current price of ₹895.9. According to 2 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Jubilant Pharmova revenue growth forecast
Expected growth rate Q1, FY2027:40.96%
Forecast
Actual
Including amortisation and stock based compensations
Jubilant Pharmova EPS growth forecast
EPS estimate Q1, FY2027:
Forecast
Actual
Source: S&P Global Market Intelligence
Key events for Jubilant Pharmova Ltd
Jubilant Pharmova Reports Strong Q3 Growth - 14 Mar, 2025
Jubilant Pharmova's stock rose 3.2% to Rs. 893.3, with a market cap of Rs. 13,780.2 crores. Q3 FY25 saw an 8.6% revenue increase to Rs. 1,822 crores and a 53% YoY net profit growth to Rs. 101 crores.Jubilant Pharmova Receives Positive Regulatory Update - 13 Mar, 2025
Jubilant Pharmova's subsidiary received a positive EIR with VAI status from the USFDA, boosting shares by 3%. However, potential US tariffs on Canadian imports create uncertainty.Jubilant Cadista Receives USFDA EIR with VAI Status - 12 Mar, 2025
Jubilant Pharmova's subsidiary, Jubilant Cadista, received a USFDA Establishment Inspection Report with Voluntary Action Indicated status for its Maryland facility, indicating improved GMP compliance. However, the facility's manufacturing operations remain shut down.Jubilant Pharmova Discloses Investor Meet Transcript - 05 Mar, 2025
Jubilant Pharmova Limited released the transcript of its Investor and Analyst Meet held on February 24, 2025, to enhance transparency. The company reported a year-to-date price performance of -16.49% and an average trading volume of 23,459, with a current market cap of 143.7 billion INR.
Insights on Jubilant Pharmova Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 3.06% to 3.64% in Dec 2024 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 1.77K Cr → 1.83K Cr (in ₹), with an average increase of 3.1% per quarter
- POSITIVE IMPACT
Price Rise
In the last 1 year, JUBLPHARMA stock has moved up by 55.9%
NO EFFECTAgainst Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.0% return, outperforming this stock by 20.4%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 50.68% of holdings in Dec 2024 quarter
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 70.5% return, outperforming this stock by 14.5%
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 17.94% to 16.96% in Dec 2024 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 25.17% to 24.83% in Dec 2024 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, 482.1 Cr → 100.9 Cr (in ₹), with an average decrease of 40.3% per quarter
Jubilant Pharmova Financials
Jubilant Pharmova Index Inclusions
Jubilant Pharmova Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 50.68% | 0.00 | |
| Foreign Institutions | 16.96% | ||
| Mutual Funds | 3.64% | 18.81 | |
| Retail Investors | 24.83% | ||
| Others | 3.9% | 23.43 |
Jubilant Pharmova Key Indicators
Jubilant Pharmova Valuation
Jubilant Pharmova in the last 5 years
Lowest (-195.50x)
December 29, 2023
Today (22.45x)
March 27, 2025
Industry (53.19x)
March 27, 2025
Highest (257.22x)
February 16, 2024
Jubilant Pharmova Earnings and Dividends
Jubilant Pharmova Ltd Earnings Results
Jubilant Pharmova Ltd’s net profit jumped 51.05% since last year same period to ₹100.90Cr in the Q3 2024-2025. On a quarterly growth basis, Jubilant Pharmova Ltd has generated -1.85% fall in its net profits since last 3-months.
Read More about Earnings ResultsJubilant Pharmova Ltd Dividends May,2024
In the quarter ending March 2024, Jubilant Pharmova Ltd has declared dividend of ₹5 - translating a dividend yield of 1.12%.
Read More about Dividends
Jubilant Pharmova Technicals Summary
Bearish
Neutral
Bullish
Jubilant Pharmova Ltd is currently in a Bearish trading position according to technical analysis indicators.
Jubilant Pharmova Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹14,156.99 Cr | 67.4% | 0.57 | ₹72 Cr | ₹6,702 Cr | |
| BUY | ₹28,261.80 Cr | 212.67% | 0.52 | ₹300 Cr | ₹1,051 Cr | |
| NA | ₹4,891.51 Cr | 14.16% | 0.79 | -₹388 Cr | ₹75 Cr | |
| BUY | ₹13,998.90 Cr | 41.24% | 0.68 | ₹218 Cr | ₹1,296 Cr | |
| BUY | ₹22,405.65 Cr | 177.61% | 0.55 | ₹258 Cr | ₹1,375 Cr |
About Jubilant Pharmova
Revenue: ₹1,813.70Cr as on December 2024 (Q4 24)
Net Profit: ₹100.70Cr as on December 2024 (Q4 24)
Listing date: 09 Nov, 1994
Chairperson Name: Shyam S Bhartia
| Organisation | Jubilant Pharmova |
| Headquarters | Noida |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on Jubilant Pharmova Ltd
What is Jubilant Pharmova Ltd price today?
Jubilant Pharmova Ltd share price today stands at ₹895.9, Open: ₹888.7, Previous Close: ₹888.7, High: ₹904, Low: ₹877.5, 52 Week High: ₹1309.9, 52 Week Low: ₹562.7.
How to Buy Jubilant Pharmova Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Jubilant Pharmova Ltd shares
What are today's traded volumes of Jubilant Pharmova Ltd?
Today's traded volume of Jubilant Pharmova Ltd(JUBLPHARMA) is 1.60L.
What is today's market capitalisation of Jubilant Pharmova Ltd?
Today's market capitalisation of Jubilant Pharmova Ltd(JUBLPHARMA) is ₹14156.99Cr.
What is the 52 Week High and Low Range of Jubilant Pharmova Ltd?
How much percentage Jubilant Pharmova Ltd is down from its 52 Week High?
Jubilant Pharmova Ltd (JUBLPHARMA) share price is ₹895.9. It is down -31.61% from its 52 Week High price of ₹1309.9
How much percentage Jubilant Pharmova Ltd is up from its 52 Week low?
Jubilant Pharmova Ltd (JUBLPHARMA) share price is ₹895.9. It is up 59.21% from its 52 Week Low price of ₹562.7